Insider · CIK 0001171788
Steven H Wunning
director
Files at KMT (KENNAMETAL INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 26, 2025 | KMT KENNAMETAL INC | AGrant or award Common Stock | +1,164 | $21.44 | $25k | 91,227 | Aug 27, 2025 |
| Aug 15, 2025 | KMT KENNAMETAL INC | MOption exercise Common Stock | +5,566 | $21.02 | $117k | 90,233 | Aug 18, 2025 |
| Aug 15, 2025 | KMT KENNAMETAL INC | FTax withholding Common Stock | -170 | $21.02 | $3,573 | 90,063 | Aug 18, 2025 |
| Aug 15, 2025 | KMT KENNAMETAL INC | MOption exercise Restricted Stock Unitsderivative | -1,773 | $0.00 | $0 | 0 | Aug 18, 2025 |
| Aug 15, 2025 | KMT KENNAMETAL INC | MOption exercise Restricted Stock Unitsderivative | -1,860 | $0.00 | $0 | 1,860 | Aug 18, 2025 |
| Aug 15, 2025 | KMT KENNAMETAL INC | MOption exercise Restricted Stock Unitsderivative | -1,933 | $0.00 | $0 | 3,867 | Aug 18, 2025 |
| Aug 15, 2025 | KMT KENNAMETAL INC | AGrant or award Restricted Stock Unitsderivative | +6,898 | $0.00 | $0 | 6,898 | Aug 18, 2025 |
| May 27, 2025 | KMT KENNAMETAL INC | AGrant or award Common Stock | +1,148 | $21.74 | $25k | 84,667 | May 29, 2025 |
| Feb 25, 2025 | KMT KENNAMETAL INC | AGrant or award Common Stock | +1,120 | $22.30 | $25k | 83,519 | Feb 26, 2025 |
| Nov 26, 2024 | KMT KENNAMETAL INC | AGrant or award Common Stock | +876 | $28.51 | $25k | 82,399 | Nov 29, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.